Differences
This shows you the differences between two versions of the page.
Both sides previous revision Previous revision Next revision | Previous revision | ||
total_cholesterol [2025/01/28 04:23] – admin | total_cholesterol [2025/01/28 05:01] (current) – admin | ||
---|---|---|---|
Line 1: | Line 1: | ||
|[[clinical_biochemistry_section|Home]]|[[clinical_biochemistry|]]|[[examination_procedures|]]| | |[[clinical_biochemistry_section|Home]]|[[clinical_biochemistry|]]|[[examination_procedures|]]| | ||
- | | + | |
- | **1.Purpose of examination:** | + | **1.Purpose of Examination:** |
- | Triglceride estimation from serum or plasma | + | To lay down standard operating procedure for serum Total Cholesterol estimation |
- | **2.Responsibility and Authority:** | + | **2.Principle of the procedure used for examinations: ** |
- | * Calibration: | + | The Cholesterol2 assay is an automated clinical chemistry assay. Cholesterol esters are enzymatically hydrolyzed by cholesterol esterase to cholesterol and free fatty acids. Free cholesterol, |
- | * Quality Control: Technician | + | (quinoneimine dye) which is quantitated at 604 nm. |
- | * Routine operation: Technician | + | |
- | * Overall Monitoring: Quality Manager | + | |
- | **3.Sample Details:** | + | **3.Performance:** |
- | * Type of Sample: Serum, | + | Linearity: upto 705mg/dl |
- | * Type of container and additives: Plain without any additives | + | Limit of Detection (LOD):Serum : 5.0 mg/dl |
- | * Patient Preparation: As per Primary Sample Collection Manual | + | Limit of Quantitation |
- | * Stability: At Room temperature 18°–28°C | + | The LOQ is the analyte concentration |
- | * Handling and transport: As per Primary Sample collection manual | + | |
- | * Storage: 24 hours at 2-8° C | + | |
- | **4.Required Equipment:** | + | **4.Type of Primary Sample:** |
- | Centrifuge, Auto-Pipette, | + | Serum or Plasma [[sample_collection_manual|]] |
- | **5.Required reagents:** | + | **5.Patient Preparation:** |
- | * R1 84ml Active ingredients: | + | Instruction should be given to the patient |
- | * 4-aminoantipyrine (0.4 mmol/L), 4-chlorophenol (2 mmol/L), | + | Verbal consent of patient should be taken before collecting blood sample. |
- | * Peroxidase (horseradish) (> 2000 U/L), GK (microbial) (> 600 U/L), | + | Patient should relax for about 5 minutes before the venepuncture.. |
- | * GPO (microbial) (> 6000 U/L), Lipoprotein lipase (microbial) (> 3000 U/L). | + | |
- | **6.Reagent Handling** | + | **6.Type of Container and additives :** |
- | * Remove any air bubbles present in the reagents | + | Plain Vaccutainer |
- | * Reagent Storage and stability | + | |
- | * Unopened reagent stable at 2-8°C until expiration date. | + | |
- | * On board System temperature reagent is stable for 30 days | + | |
- | * Instability or deterioration should be suspected if there are precipitates, | + | |
- | * contamination, | + | |
+ | **7.Required Equipment and reagents:** | ||
+ | Centrifuge, Auto-Pipette, | ||
+ | **8.Enviromental & Safety control:** | ||
+ | Reagent R1 contains sodium azide. contact with acids liberates very toxic gas | ||
- | **7.Calibration Procedure:** | + | **9.Precautions:** |
- | * Consolidated Chemistry Calibrator | + | Wear protective gloves / protective clothing / eye protection |
- | * Frequency: | + | Do not breathe mist / vapors / spray |
- | * Reagent lot change | + | Wash hands thoroughly after handling |
- | * QC out of range | + | Keep only in original container |
- | * After service or maintenance | + | |
- | * Replacement | + | |
- | **8.Procedure: | + | **10.Calibration |
- | | + | Give Calibration with Consolidated Chemistry |
- | | + | **Manual calibration is done on following circumstances: |
- | | + | |
- | | + | |
- | | + | |
- | - Go to the calibration and give the calibration order. | + | Note: Verify calibration with at least two levels of controls |
- | - Verify calibration with at least two levels of controls. | + | |
- | - If control results fall outside acceptable ranges,root cause analysis or recalibration may be necessary. | + | |
- | **9.Quality control Procedure:** | + | **11.Procedural Steps:** |
- | * ** Name:** Bio Rad Level 1 & 2 | + | * Verify that all necessary reagents present |
- | * **Frequency: | + | |
+ | | ||
+ | * Press run. | ||
- | **Procedure | + | **12.Quality Control |
- | - Reconstitution of QC material with 5 ml Distilled water by using calibrated fixed volume pipette. | + | The Laboratory runs Lypocheck Assayed Chemistry Control level 1 & level 2 Once a day. Monthly L-J charts are reviewed & for any QC outlier root cause analysis are done & corrective actions are taken according |
- | - Leave to stand for 30 min in the dark place. | + | The Laboratory Participates in EQAS programme EQAS report is reviewed and if any result go outlier, then root cause analysis is done & corrective actions |
- | - Swirl gently several times during the reconstitution period to ensure that the contents | + | |
- | - Prior to use, mix the contents by inverting the vial. Do not shake the vial as the information of foam should be avoided. Ensure that no lyophilized material remains un-reconstituted. | + | |
- | - Prepare aliquots of 150 µl from the reconstituted QC material. | + | |
- | - Store these aliquots at -15° C to -20° C. | + | |
- | - Prior to use, make sure that aliquots should be at room temperature for at least 15 min. | + | |
- | **Procedure to run IQC** | + | **13.Interferences & Cross-Reactions: |
- | - Press Control order | + | InterferingSubstance |
- | | + | |
- | | + | |
- | | + | |
- | - Press F3 / Add order | + | |
- | | + | |
- | - Check IQC results, in case outliers call residents. | + | |
- | **10.Principle of the procedure used for examinations:** | + | **14.Principle of Procedure |
- | Triglycerides are enzymatically hydrolyzed by lipase to free fatty acids and glycerol. The glycerol is phosphorylated by adenosine triphosphate (ATP) with glycerol kinase (GK) to produce glycerol-3-phosphate and adenosine diphosphate (ADP). Glycerol-3-phosphate is oxidized to dihydroxyacetone phosphate (DAP) by glycerophosphate oxidase (GPO) producing hydrogen peroxide (H2O2). In a color reaction catalyzed by peroxidase, | + | Instrument measures |
+ | Sample Concentration: | ||
+ | Cs = Sample Concentration | ||
+ | K = Constant | ||
+ | As = Sample Absorbance | ||
+ | Measurement uncertainty: | ||
+ | Highest CV% of last 6 months | ||
+ | Refer Annexure I | ||
- | **11.Sample Preparation:** | + | **15.Biological Reference Interval:** |
- | * Required SampleVolume: 150 µl of the sample | + | Adult : < |
- | * Temperature: | + | |
- | * Take 150-200µl of the sample from Primary tube to the secondary aliquot. Write the sample ID on the aliquot. | + | |
- | **Procedure to run Patient sample** | + | **16.Reportable interval of patient examination results:** |
- | - Press Patient order | + | Up to 500mg/dl |
- | - Select Assay / | + | |
- | - Give Carrier Number and Position number | + | |
- | - Press F3 / Add order | + | |
- | - Put respected carrier in RSH rack | + | |
- | **12.Performance Characteristics**: | + | |
- | | + | |
- | | + | |
- | | + | |
- | - Unit: mg/dL | + | |
- | **Normal and critical ranges:** | + | **17.Manual Dilution Procedure:** |
+ | * Dilute the specimen with saline (0.85% to 0.90% NaCl). | ||
+ | * Enter the dilution factor in the Patient or Control order screen | ||
- | **Triglyceride** | + | **18.Stability of sample** |
- | ^Desirable^ Borderline High^High^ | + | Serum or plasma-At Room temperature18°–28°C (64°–82°F) stability ≤ 24 hours |
- | |< | + | |
+ | **19.Storage of sample** | ||
+ | 2-8° C for 1 days (Retention period for re-examination and/or additional tests is 24 hrs.) | ||
+ | |||
+ | **20.Reagent Storage and stability** | ||
+ | Reagent is stored at 2-8 °c.Reagent stability is 30 days if the reagent is uncapped and on board. | ||
- | **13.Laboratory Clinical interpretation: | + | **21.Turn around time (TAT)** |
- | The common causes of hyperlipidemia is nephrosis,DM, | + | 6.0 hours after collection,in case of emergency 2.0 hours |
- | **14.Interference and cross reaction:** | + | **22.Critical Value:**NA |
- | InterferingSubstance | + | **23.Laboratory Interpretation: |
- | | + | The common causes of high cholesterol level are as follows : |
- | | + | |
- | * No interference from Ascorbate up to 1.5 mg/dl | + | |
- | | + | |
- | | + | |
- | * No interference from N acetyl L cystenine up to800 mg/dl | + | |
- | **15.Potential source of variation: | + | **24.Potential source of variation: |
- | | + | |
- | | + | |
- | | + | |
+ | - Instrumental Error | ||
+ | - Reagent contamination | ||
+ | - Storage condition not proper | ||
- | **16.Recording of observation: | + | **25.Reagent Handling** |
- | * Software backup | + | Remove any air bubbles present in the reagents with a new applicator stick, or allow the reagents to sit at the appropriate storage temperature to allow the bubbles to dissipate. To minimize volume depletion, do not use a transfer pipette to remove bubbles |
- | * Machine raw data | + | |
- | **17.torage & Disposal of waste:** Follow storage & discard procedure | + | |
- | **18.Environmental & Safety control: | + | **26.REFERENCE:** |
- | + | ||
- | **Reagent R1** contains sodium azide.contact with acids liberates very toxic gas | + | |
- | + | ||
- | **19.Precautions: | + | |
- | - Wear protective gloves / protective clothing / eye protection | + | |
- | - Do not breathe mist / vapors / spray | + | |
- | - Wash hands thoroughly after handling | + | |
- | - Keep only in original container | + | |
- | . | + | |
- | **20.References:** | + | |
- US department of labor, | - US department of labor, | ||
- US department of health and human services. Biosafety in MIcrobiological and biomedical laboratories. | - US department of health and human services. Biosafety in MIcrobiological and biomedical laboratories. | ||
Line 146: | Line 123: | ||
- Clinical and laboratory std institute . Protection of Laboratory workers from oocupationally acquired infection; Approved guideline -4th edition. | - Clinical and laboratory std institute . Protection of Laboratory workers from oocupationally acquired infection; Approved guideline -4th edition. | ||
- Burtis CA,Ashwood ER, | - Burtis CA,Ashwood ER, | ||
+ | - ARCHITECT | ||
+ | - NABL 112 effective from 01/06/2019 | ||
|**Printed copy of this document is considered uncontrolled.** It should be compared with controlled electronic copy before use| | |**Printed copy of this document is considered uncontrolled.** It should be compared with controlled electronic copy before use| | ||
^ Name of Laboratory : Laboratory Services Sir T. Hospital (LSSTH), | ^ Name of Laboratory : Laboratory Services Sir T. Hospital (LSSTH), | ||
- | ^Document No.1^**Document Name**: | + | ^Document No.1^**Document Name**: |
^Issue No. : 01^Issue Date : | ^Issue No. : 01^Issue Date : | ||
^Amend No.^ Amend Date ^Prepared by: Section Incharge^Approved & Issued by: HOD, | ^Amend No.^ Amend Date ^Prepared by: Section Incharge^Approved & Issued by: HOD, | ||
+ |